Liabilities / Assets
46th percentile
Tied with the lowest-debt nonprofits in its peer group.
990 • Fiscal year 2016 • EIN 46-5635605
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
46th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
46th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
94th percentile
Higher net margin than 94% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
99th percentile
Faster asset growth than 99% of similar nonprofits.
Revenue Growth
95th percentile
Faster revenue growth than 95% of similar nonprofits.
Assets
Up$233,735
Up $190,341 (+439%) from 2015
Net Assets
Up$233,735
Up $190,341 (+439%) from 2015
Liabilities
Flat$0
Flat from 2015
Revenue
Up$321,735
Up $134,235 (+72%) from 2015
Expenses
Up$207,315
Up $63,209 (+44%) from 2015
Net Income
Up$114,420
Up $71,026 (+164%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To support companies who are committed to the production and research of natural astaxanthin derived from Haematococcus Pluvialis, while promoting health benefits, supporting public education and safety, and product quality and testing standards, while advancing government, health care, and industry relations.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.